2003
DOI: 10.1590/s0104-66322003000100004
|View full text |Cite
|
Sign up to set email alerts
|

Identification of two potential receptor-binding sites for hGM-CSF

Abstract: Two receptor-binding sites for hGM-CSF are described. Competitive binding ELISA using four monoclonal antibodies (MAbs) showed different epitope recognitions. The antibody combining sites were mapped using sets of overlapping peptides and hexapeptide libraries prepared by the SPOT synthesis technique. We identified the conformationally dependent epitopes A18E21R23R24F119 and R23E21N17W13 bound by MAb CC5B5 and the nonlinear epitope P118F119W13E14 bound by MAb M1B8. The epitopes recognized by these two MAbs are… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2003
2003
2015
2015

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 12 publications
0
1
0
Order By: Relevance
“…17 Eberhardt and coworkers used a panel of monoclonal antibodies targeting GM-CSF to characterize their epitope specificities. 47 To identify discontinuous epitopes, they used combinatorial hexapeptide libraries and peptide scans. They could identify the conformation-dependent epitopes from helix A and the C-terminal tail of GM-CSF A18-E21-R23-R24-F119 and R23-E21-N17-W13 being bound by a moderately neutralizing monoclonal antibody called CC5B5.…”
Section: Discussionmentioning
confidence: 99%
“…17 Eberhardt and coworkers used a panel of monoclonal antibodies targeting GM-CSF to characterize their epitope specificities. 47 To identify discontinuous epitopes, they used combinatorial hexapeptide libraries and peptide scans. They could identify the conformation-dependent epitopes from helix A and the C-terminal tail of GM-CSF A18-E21-R23-R24-F119 and R23-E21-N17-W13 being bound by a moderately neutralizing monoclonal antibody called CC5B5.…”
Section: Discussionmentioning
confidence: 99%